Anti-CD19 chimeric antigen receptor T-cell therapy in B-cell lymphomas: current status and future directions

AIMS: To review recent data and relevant of the role of anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for B-cell non-Hodgkin lymphoma (NHL). METHODS: Review and compilation of the most recent and relevant data published in full text and abstract forms of anti-CD19 CAR T-cell therapy for B...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavez, Julio C, Yassine, Farah, Sandoval-Sus, Jose, Kharfan-Dabaja, Mohamed A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445151/
https://www.ncbi.nlm.nih.gov/pubmed/34540198
http://dx.doi.org/10.2217/ijh-2020-0021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445151/
https://www.ncbi.nlm.nih.gov/pubmed/34540198
http://dx.doi.org/10.2217/ijh-2020-0021

Ejemplares similares